p. 1263 - 1266
(2007/10/03)p. 23 - 30
(2007/10/02)p. 948 - 950
(2007/10/02)p. 3469 - 3470
(2007/10/02)p. 4187 - 4190
(2007/10/02)p. 43 - 47
(2007/10/02)(3β)-9,10-Didehydro-2,3-dihydro-1-<(4-methoxyphenyl)sulfonyl>-6-methyl-8-methyleneergoline
(+/-)-norisochanoclavine-I
[(4R,5S)-5-(2-Methyl-propenyl)-1,3,4,5-tetrahydro-benzo[cd]indol-4-yl]-carbamic acid methyl ester
Methyl-[(4R,5S)-5-(2-methyl-propenyl)-1,3,4,5-tetrahydro-benzo[cd]indol-4-yl]-amine
(4R,5S)-5-(2-Methyl-propenyl)-1,3,4,5-tetrahydro-benzo[cd]indol-4-ylamine